Globus Medical to participate in the Canaccord Genuity 2025 Musculoskeletal Conference
AUDUBON, Pa., March 05, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced it is scheduled to participate in the Canaccord Genuity 2025 Musculoskeletal Conference in San Diego. Management is scheduled to present on Monday, March 10, 2025 at 4:30 pm PT.
Interested parties can access the live and archived webcast of the presentation in the 'News & Events', 'Events & Webcasts' section of the Globus Medical investor relations website at https://www.investors.globusmedical.com/news-events/events-webcasts.
About Globus Medical, Inc. Based in Audubon, Pennsylvania, Globus Medical, Inc. is a leading global musculoskeletal technology company dedicated to solving unmet clinical needs and changing lives. We innovate with inspired urgency, provide world-class education and clinical support, and advance care throughout spine, orthopedic trauma, joint reconstruction, regenerative biomaterials and enabling technologies. Additional information can be accessed at www.globusmedical.com.
Investor contact: Brian Kearns 610-930-1800 investors@globusmedical.com
Media contact: Moran Chavez media@globusmedical.comSign in to access your portfolio
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Insider
33 minutes ago
- Business Insider
RBC Capital Remains a Buy on Brookfield Infrastructure (BIP)
In a report released yesterday, Maurice Choy from RBC Capital maintained a Buy rating on Brookfield Infrastructure, with a price target of $40.00. The company's shares closed yesterday at $31.14. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Choy covers the Utilities sector, focusing on stocks such as Canadian Utilities A, ATCO Ltd Cl I NV, and Brookfield Infrastructure. According to TipRanks, Choy has an average return of 9.9% and a 66.67% success rate on recommended stocks. In addition to RBC Capital, Brookfield Infrastructure also received a Buy from Scotiabank's Robert Hope in a report issued yesterday. However, on July 29, TR | OpenAI – 4o reiterated a Hold rating on Brookfield Infrastructure (NYSE: BIP). Based on Brookfield Infrastructure's latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $5.39 billion and a net profit of $106 million. In comparison, last year the company earned a revenue of $5.19 billion and had a net profit of $131 million
Business Insider
33 minutes ago
- Business Insider
RBC Capital Reaffirms Their Hold Rating on Two Harbors (TWO)
In a report released on July 31, Kenneth Lee from RBC Capital maintained a Hold rating on Two Harbors, with a price target of $10.00. The company's shares closed yesterday at $9.78. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Lee covers the Financial sector, focusing on stocks such as Invesco, Artisan Partners, and OneMain Holdings. According to TipRanks, Lee has an average return of 18.8% and a 74.25% success rate on recommended stocks. In addition to RBC Capital, Two Harbors also received a Hold from BTIG's Eric Hagen in a report issued yesterday. However, on July 29, Maxim Group reiterated a Buy rating on Two Harbors (NYSE: TWO).
Yahoo
34 minutes ago
- Yahoo
Lockheed Martin (LMT) Sees Sequential Growth in Q2 2025 Sales
Lockheed Martin Corporation (NYSE:LMT) is one of the Best 52-Week Low Blue Chip Stocks to Buy Now. The company reported Q2 2025 results on July 22. In Q2 2025, the company's sales of $18 billion saw a sequential growth as it continues to fuel supply chain improvements and ramp capacity on the required deterrent capabilities. Additionally, the company invested $800 million in infrastructure and innovation for growth and returned $1.3 billion to shareholders in the form of dividends and share repurchases. A military aircraft in flight, showing the strength of the company's combat & air mobility capability. Lockheed Martin Corporation (NYSE:LMT)'s Aeronautics segment saw an increase of $143 million, or 2% YoY, in sales during the quarter ended June 29, 2025. This was mainly because of increased sales of $470 million on the F-35 program as a result of higher volume on production contracts. This increase was partially mitigated by a $360 million unfavorable cumulative adjustment to sales due to the loss on a classified contract. For FY 2025, Lockheed Martin Corporation (NYSE:LMT) expects sales in the range of ~$73,750 million – $74,750 million, and FCF of between ~$6,600 million – $6,800 million. Lockheed Martin Corporation (NYSE:LMT)'s Missiles and Fire Control segment witnessed an increase of $331 million, or 11% YoY, in sales during the quarter ended June 29, 2025. This was mainly due to higher sales of $330 million on tactical and strike missile programs because of production ramp-up on Joint Air-to-Surface Standoff Missile (JASSM), Long Range Anti-Ship Missile (LRASM), and precision fires programs. While we acknowledge the potential of LMT as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 13 Cheap AI Stocks to Buy According to Analysts and 11 Unstoppable Growth Stocks to Invest in Now Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
